The Delaware Supreme Court’s ruling in Cantor Fitzgerald v. Ainslie, which reversed the Court of Chancery’s 2023 finding ...

President Trump’s nominees for Health secretary, Commerce secretary, and Small Business Administration administrator are ...

President Donald Trump’s budget office has rescinded an order freezing spending on federal grants, less than two days after it sparked widespread confusion and legal challenges across the country, acc ...

Western Digital which will be splitting its business by the end of February remains confident to benefit from the rising AI ...

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue ...

Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the ...

Analysts at Cantor Fitzgerald said in a research note that the results “could not have been better.” Lilly meanwhile is planning a phase 3 trial of selpercatinib that would be used to confirm ...

Trump has appointed two tech figures – Elon Musk and Vivek Ramaswamy – to lead a cost-cutting effort dubbed the "Department ...

Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.

Cantor Fitzgerald currently has a “Overweight” rating and a $44.00 price objective on the stock. The consensus estimate for Sanara MedTech’s current full-year earnings is ($1.33) per share.